TL/DR -
A new report by HealthView Services has highlighted a substantial hike in 2024 premiums for Medicare Part D prescription drug plans in five US states, contradicting earlier predictions by the Centers for Medicare & Medicaid Services that these would decline due to the Inflation Reduction Act. The report shows retirees using Part D…